In particular, IGF/IGF-IR-independent actions of IGFBP3 have been shown to contribute to the pathophysiology of a variety of human diseases, such as cancer, diabetes, and Alzheimer’s disease [27]. Here, IGFBP3 is linked to early-onset autosomal dominant Alzheimer disease.